Early detection of diabetic nephropathy;Detecção precoce da nefropatia diabética

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 52, Issue 3, 2008, Pages 442-451

  Murussi, Marcia ^a   Murussi, Nádia ^a   Campagnolo, Nicole ^a   Silveiro, Sandra Pinho ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Diabetic nephropathy; Glomerular filtration rate; MDRD; Microalbuminuria; Urinary albumin excretion

Indexed keywords

ALBUMINOID; BIOLOGICAL MARKER; CYSTATIN C; PROTEOME;

ALBUMINURIA; DIABETIC NEPHROPATHY; EARLY DIAGNOSIS; GLOMERULUS FILTRATION RATE; HUMAN; METHODOLOGY; PROTEOMICS; REVIEW; URINE;

ALBUMINS; ALBUMINURIA; BIOLOGICAL MARKERS; CYSTATIN C; DIABETIC NEPHROPATHIES; EARLY DIAGNOSIS; GLOMERULAR FILTRATION RATE; HUMANS; PROTEOME; PROTEOMICS;

EID: 44949216781     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302008000300004     Document Type: Review

References (85)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes. Diabetes Care. 2004;27:1047-53.
2. Nucci LB, Toscano CM, Maia AL, Fonseca CD, Brito MM, Duncan BB, et al. Brazilian national campaign for diabetes mellitus detection working group. Rev Panam Salud Publica. 2004;16:320-7.
3. Ruggenenti P, Remuzzi G. Nephropathy of type 2 diabetes mellitus. J Am Soc Nephrol. 1998;9:2157-69.
4. Gross JL, Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care. 2005;28:164-76.
5. Murussi M, Baglio P, Gross JL, Silveiro SP. Risk factors for microalbuminuria and macroalbuminuria in type 2 diabetic patients. Diabetes Care. 2002;25:1101-3.
6. Forsblom CM, Groop PH, Ekstrand A, Tötterman KJ, Sane T, Saloranta C, et al. Predictors of progression from normoalbuminuria to microalbuminuria in NIDDM. Diabetes Care. 1998;21:1932-8.
7. Ravid M, Brosh D, Ravid-Safran D, Levy Z, Rachmani R. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Arch Intern Med. 1998;158:998-1004.
8. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR. Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int. 2003;63:225-32.
9. Ansell D, Feest T. The Second Annual Report, in the UK Renal Registry. Bristol, The UK Renal Registry. Southmead Hospital; 1999.
10. US Renal Data System. Annual data report. Am J Kidney Dis. 2005;45:S69-80.
11. Bruno RM, Gross JL. Prognostic factors in brazilian diabetic patients starting dialysis: a 3.6-year follow-up study. J Diabetes Complications. 2000;14:226-71.
12. Moloney A, Tunbridge WM, Ireland JT, Watkins PJ. Mortality from diabetic nephropathy in the United Kingdom. Diabetologia. 1983;25:26-30.
13. Anavekar NS, Gans DJ, Berl T, Rohde RD, Cooper W, Bhaumik A, et al. Predictors of cardiovascular events in patients with type 2 diabetic nephropathy and hypertension: A case for albuminuria. Kidney Int. 2004;66(Suppl 92):S50-5.
14. Gross JL, Silveiro SP, Canani LH, Friedman R, Leitão CB, de Azevedo MJ. Diabetic nephropathy and cardiac disease. Arq Bras Endocrinol Metabol. 2007;5:244-56.
15. Go AS, Cherlow GM, Fan D, McClloch CE, Hsu C. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296-305.
16. Chantrel F, Enache I, Bouiller M, Kolb I, Kunz K, Petitjean P, et al. Abysmal prognosis of patients with type 2 diabetes entering dialysis. Nephrol Dial Transplant. 1999;14:129-36.
17. De Zeeuw D. Albuminuria, not only a cardiovascular/renal risk marker, but also a target for treatment? Kidney Int. 2004;66(Suppl 92):S2-6.
18. Mogensen CE, Vestbo E, Poulsen PL, Christiansen C, Damsgaard E, Eiskjer H, et al. Microalbuminuria and potential confounders. A review and some observation on variability of urinary albumin excretion. Diabetes Care. 1995;18:572-81.
19. American Diabetes Association. Diabetic nephropathy (position statement). Diabetes Care. 2004;27 (Suppl 1):S79-83.
20. Murussi M, Coester A, Gross JL, Silveiro SP. Nefropatia diabética no diabete melito tipo 2: fatores de risco e prevenção. Arq Bras Endocrinol Metabol. 2003;47:207-19.
21. Zelmanovitz T, Gross JL, Oliveira J, Paggi A, Tatsch M, Azevedo MJ. The receiver operating characteristics curve in the evaluation of a random urine specimen as a screening test for diabetic nephropathy. Diabetes Care. 1997;20:516-9.
22. Incerti J, Zelmanovitz T, Camargo JL, Gross JL, de Azevedo MJ. Evaluation of tests for microalbuminuria screening in patients with diabetes. Nephrol Dial Transplant. 2005;20:2402-7.
23. Leitão CB, Canani LH, Polson PB, Molon MP, Pinotti AF, Gross JL. Urinary albumin excretion rate is associated with increased ambulatory blood pressure in normoalbuminuric type 2 diabetic patients. Diabetes Care. 2005;28:1724-9.
24. Rachmani R, Levi Z, Lidar M, Slavachevski J, Half-Onn E, Ravid M. Considerations about the threshold value of microalbuminuria in patients with diabetes mellitus: lessons from an 8-year follow-up study of 599 patients. Diabetes Res Clin Pract. 2000;49:187-94.
25. Murussi M, Campagnolo N, Beck Mo, Gross JL, Silveiro SP. High-normal levels of albumin predict development of micro- and macroalbuminuria and increased mortality in Brazilian type 2 diabetes mellitus patients: an 8-year follow-up study. Diabet Med. 2007;24;1136-42.
26. Comper DW, Osicka TM, Jerums G. High prevalence of immuno-unreactive intact albumin in urine of diabetic patients. Am J Kidney Dis. 2003;41:336-42.
27. Brinkman JW, Bakker SJL, Gansevoort RT, Hans LH, Kema IP, Gans OBR. Which method for quantifying urinary albumin excretion gives what outcome? A comparison of immunonephelometry with HPLC. Kidney Int. 2004;66(Suppl 92):S69-75.
28. Comper WD, Osicka TM, Clarck M, MacIsaac RJ, Jerums G. Earlier detection of microalbuminuria in diabetic patients using a new urinary albumin assay. Kidney Int. 2004;65:1850-5.
29. MacIsaac RJ, Tsalamandris C, Panagiotopoulos S, Smith TJ, McNeil KJ, Jerums G. Nonalbuminuric renal insufficiency in type 2 diabetes. Diabetes Care. 2004;27:195-200.
30. Kramer HJ, Nguyen QD, Curhan G, Ilsu C. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA. 2003;289:3273-7.
31. Kramer CK, Leitão CB, Pinto LC, Silveiro SP, Gross JL, Canani LH. Clinical and laboratory profile of patients with type 2 diabetes mellitus with low glomerular filtration rate and normoalbuminuria. Diabetes Care. 2007, Apr, in press.
32. Caramori ML, Fioretto P, Mauer M. The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient? Diabetes. 2000;49:1399-408.
33. Murussi M, Campagnolo N, Coester A, Beck MO, Gross JL, Silveiro SP. Course of microalbuminuria in type 2 diabetic patients: a 5-year follow-up study. In: European Association for the Study of Diabetes, 2006, Copenhagen, Diabetologia. 2006;49:1-1.
34. Schmitz A, Vaeth M, Mogensen CE. Systolic blood pressure relates to the rate of progression of microalbuminuria in NIDDM. Diabetologia. 1994;37:1251-8.
35. John L, Sunder Rao PSS, Kanagasabapathy AS. Rate of progression of albuminuria in type II diabetes. Diabetes Care. 1994;17:888-90.
36. Murussi M, Gross JL, Silveiro SP. Glomerular filtration rate changes in normoalbuminuric and microalbuminuric type 2 diabetic patients and normal individuals. A ten-year follow-up. J Diabetes Complications. 2006;20:210-5.
37. Mattock MB, Morrish NJ, Viberti G, Keen H, Fitzgerald AP, Jackson G. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes. 1992;41:736-41.
38. Hillege HL, Janssen WM, Bak AA, Diercks GF, Grobbee DE, Crijns HJ, et al . Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med. 2001;249:519-26.
39. The Microalbuminuria Collaborative Study Group. Predictors of the development of microalbuminuria in patients with type 1 diabetes mellitus: a seven-year prospective study. Diabet Med. 1999;16:918-25.
40. Mogensen CE, Damsgaard EM, Froland A, Nielsen S, de Fine Olivarius N, Schmitz A. Microalbuminuria in non-insulin-dependent diabetes. Clin Nephrol. 1992;38:S28-38.
41. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The steno hypothesis. Diabetologia. 1989;32:219-26.
42. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139:137-47.
43. Eknoyan G, Hostetter T, Bakris GL, Hebert L, Levey AS, Parving HH, et al. Proteinuria and other markers of chronic kidney disease: a position statement of the National Kidney Foundation (NKF) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Am J Kidney Dis. 2003;42:617-22.
44. Parving H-H, Oxenboll B, Svendesen PA, Christiansen JS, Andersen AR. Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion. Acta Endocrinol (Copenh). 1982;100:550-5.
45. Viberti GC, Hill RD, Jarret RJ, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet. 1982;1:1430-2.
46. Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med. 1984;311:89-93.
47. Gall MA, Hougaard P, Borch-Johnsen K, Parving HH. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study. BMJ. 1997;314:783-8.
48. Gilbert RE, Tsalamandris C, Bach LA, Panagiotopoulos S, O'Brien RC, Allen TJ, et al. Long-term glycemic control and the rate of progression of early diabetic kidney disease. Kidney Int. 1993;44:855-9.
49. Mathiesen ER, Ronn B, Storm B, Foght H, Deckert T. The natural course of microalbuminuria in insulin-dependent diabetes: a 10-year prospective study. Diabet Med. 1995;12:482-7.
50. Microalbuminuria Collaborative Study Group, United Kingdom: Intensive therapy and progression to clinical albuminuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. BMJ. 1995;311:973-7.
51. Ruggenenti P, Gambara V, Perna A, Bertani T, Remuzzi G. The nephropathy of non-insulin-dependent diabetes: Predictors of outcome relative to diverse patterns of renal injury. J Am Soc Nephrol; 1998;9:2336-43.
52. Atkins RC, Briganti EM, Lewis JB, Hunsicker LG, Braden G, Chanpion de Crespigny PJ, et al. Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy. Am J Kidney Dis. 2005;45:281-7.
53. Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med. 1998;12:1448-56.
54. Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen, et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation. 2002;106:1777-82.
55. Klausen K, Borsch-Johnsen K, Feldt-Rasmussen B, Jensen G, Clausen P, Scharling H, et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation. 2004;110:32-5.
56. Arnlov, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D, et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation. 2005;112:969-75.
57. Comper DW, Jereums G, Osicka TM. Differences in urinary albumin detected by four immunoassays and high-performance liquid chromatography. Clin Biochem. 2003;37:105-11.
58. Russo LM, Bakris GL, Comper WD. Renal handling of albumin: a critical review of basic concepts and perspective. Am J Kidney Dis. 2002;39:899-919.
59. McQueen MJ, Gerstein HC, Pogue J, Mann JFE, Yusuf S. Reevaluation by high-performance liquid chromatography: clinical significance of microalbuminuria in individuals at high risk of cardiovascular disease in the Heart Outcomes Prevention Evaluation (HOPE) study. Am J Kidney Dis. 2006;48:889-96.
60. Leitão CB, Canani LH, Bolson PB, Molon MP, Silveiro SP, Gross JL. Que valores devem ser adotados para diagnosticar microalbuminúria em pacientes com diabete melito? Arq Bras Endocrinol Metabol. 2006;50:322-6.
61. Ruggenenti P, Remuzzi G. Time to abandon microalbuminuria? Kidney Int. 2006;70:1214-22.
62. Tsalamandris C, Allen TJ, Gilbert RE, Sinha A, Panagiotopoulos S, Cooper ME, et al. Progressive decline in renal function in diabetic patients with and without albuminuria. Diabetes. 1994;43:649-55.
63. Knobler H, Zornitzki T, Vered S, Oettinger M, Levy R, Caspi A, et al. Reduced glomerular filtration rate in asymptomatic diabetic patients. Predictor of increased risk for cardiac events independent of albuminuria. J Am Coll Cardiol. 2004;44:2142-8.
64. Caramori ML, Fioretto P, Mauer M. Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: an indicator of more advanced glomerular lesions. Diabetes. 2003;52:1036-40.
65. Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, et al. Chronic kidney disease epidemiology collaboration. Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem. 2007;766-72.
66. Rossing P, Astrup AS, Smidt UM, Parving HH. Monitoring kidney function in diabetic nephropathy. Diabetologia. 1994;37:708-12.
67. Nielsen S, Rehling M, Schmitz A, Mogensen CE. Validity of rapid estimation of glomerular filtration rate in type 2 diabetic patients with normal renal function. Nephrol Dial Transplant. 1999;14:615-9.
68. Chudleigh RA, Dunseath G, Evans W, Harvey JN, Evans P, Ollerton R, et al. How reliable is estimation of glomerular filtration rate at diagnosis of type 2 diabetes? Diabetes Care. 2007;30:300-5.
69. Ross JF, Doust J, Tett SE, Kirkpatrick CMJ. Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children - a meta-analysis. Clin Biochem. 2007;40:383-91.
70. Prates AB, Amaral FB, Vacaro MZ, Gross JL, Camargo JL, Silveiro SP. Avaliação da filtração glomerular através da medida da cistatina C sérica. J Bras Nefrol. 2007;29:48-55.
71. MacIsaac RJ, Tsalamandris C, Thomas MC, Premaratne E, Panagiotopoulos S, Smith TJ, et al. The accuracy of cystatin C and commonly used creatinine-based methods for detecting moderate and mild chronic kidney disease in diabetes. Diabet Med. 2007;24:443-8.
72. Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med. 2005;352:2049-60.
73. Donahue RP, Stranges S. Elevated cystatin-C concentration and progression to prediabetes: the Western New York study. Diabetes Care. 2007;30:300-5.
74. o Congresso Brasileiro de Clínica Médica, 2005.
75. Pucci L, Triscornia S, Lucchesi D, Fotino C, Pellegrini G, Pardini E, et al. Cystatin C and estimates of renal function: searching for a better measure of kidney function in diabetic patients. Clin Chem. 2007;53:480-8.
76. Rao PV, Lu X, Standley M, Pattee P, Neelima G, Girisesh G, et al. Proteomic Identification of Urinary Biomarkers of Diabetic Nephropathy. Diabetes Care. 2007;30:629-37.
77. Mischak H, Kaiser T, Walden M, Hillmann M, Wittke S, Herrmann A, et al. Proteomic analysis for the assesment of diabetic renal damage in humans. Clin Sci. 2004;107:485-95.
78. Hewitt SM, Dear J, Star RA. Discovery of protein biomarkers for renal disease. J Am Soc Nephrol. 2004;15:1677-89.
79. Thongboonkerd V, Barati MT, Mcleish KR, Benarafa C, Remold O'Donnell E, Zheng S, et al. Alterations in the renal elastinelastase system in type 1 diabetic nephropathy identified by proteomic analysis. J Am Soc Nephrol. 2007;15:650-62.
80. Thongboonkerd V, Malasit P. Renal and urinary proteomics: Current applications and challenges. Proteomics. 2004;5:1033-42.
81. Vidal BC, Bonventre JV, I-Hong HSU S. Towards the application of proteomics in renal disease diagnosis. Clin Sci. 2005;109:421-30.
82. Meier M, Kaiser T, Herrmann A, Knueppel, Hillmann M, Koester P, et al. Identification of urinary protein pattern in Type 1 diabetic adolescents with early diabetic nephropathy by novel combined proteome analysis. J Diabetes Complications. 2005;19:223-32.
83. Fliser D, Novak J, Thongboonkerd V, Argiles A, Jankowski V, Girolami MA, et al. Advances in urinary proteome analysis and biomarker discovery. J Am Soc Nephrol. 2007;18:1057-71.
84. Out HH, Can H, Spentzos D, Nelson R, Hanson RL, Looker HC, et al. Prediction of diabetic nephropathy using urine proteomic profiling 10 yeas prior to development of nephropathy. Diabetes Care. 2007;30:638-43.
85. Kim H-J, Cho E-H, Yoo J-H, Kim P-K, Shin J-S, Kim M-R, et al. Proteome analysis of serum from type 2 diabetics with nephropathy. J Proteome Res. 2007;6:735-43.